Brought to you by 
CareX raises €25mm in Series B round
02 Apr 2004
Executive Summary
CareX SA (studies gene expression to develop drugs for metabolic and cardiovascular diseases) closed its Series B round, raising €25mm ($32mm). New investor Index Ventures led the oversubscribed round, and was joined by other new backers Credit Lyonnais Private Equity, Global Life Science Ventures, and BioMedinvest, as well as returning participants Sofinnova Partners, GIMV, and Mara Venture Partners.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CareX raises €25mm in Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice